期刊
MINI-REVIEWS IN MEDICINAL CHEMISTRY
卷 9, 期 6, 页码 664-673出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138955709788452739
关键词
Obesity; drug treatment; orlistat; sibutramine; rimonabant; leptin; ghrelin
资金
- Instituto Carlos III [PI051024, PI070413]
- Xunta de Galicia [PS07/12, Redes 2006/27]
Available anti-obesity pharmacotherapy options remain very limited. The development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake, by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacological treatment options.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据